eli lily glp-1 Lilly's oral pill may help people with Type 2 diabetes lose 'significant' weight, study finds Administration Anounces Landmark GLP-1 Pricing

Webinars for Insurance Agents Get Connected: Register with Ritter Insurance Marketing the FMO that powers the Agent Survival Guide Podcast

Experiencing lightheadedness on tirzepatide

We Are Open 5 Days a Week.

The Risks: Unknown ingredients and contamination Incorrect dosages and life-threatening side effects No regulatory oversight or safety data Why This Is Critical: Patients are bypassing pharmacies and getting injections from sketchy online vendors This undermines real GLP1 therapies and can lead to serious harm As healthcare professionals, we must: Ask patients about the source of their medications Report adverse reactions to MedWatch Educate our patients about safe access and real prescriptions Lets advocate for ethical prescribing and responsible patient care in the GLP1 era

Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on the glucagon-like peptide-1 (GLP-1), the Lasker Foundation announced last Thursday.

Okava Pharmaceuticals, a clinical-stage company developing medicines for cats and dogs, announced a new clinical trial testing a GLP-1 implant for cats on Tuesday.